Should mast cells be considered therapeutic targets in multiple sclerosis?

Area of Science:

• Immunology
• Neuroscience
• Pharmacology

Background:

• Mast cells are myeloid immune cells present throughout the body, including the central nervous system.
• These cells play crucial roles in innate and specific immunity, angiogenesis, and vascular homeostasis.
• Mast cells are implicated in various pathologies, such as hypersensitivity reactions, tumors, and inflammatory disorders.

Purpose of the Study:

• To propose mast cells as a relevant therapeutic target for multiple sclerosis (MS), a central nervous system degenerative disease.
• To review the biological properties of mast cells and their contribution to immune responses.
• To examine the involvement of mast cells in the pathogenesis of MS and experimental autoimmune encephalomyelitis (EAE).

Main Methods:

• Review of existing literature on mast cell biology and their role in neuroinflammation.
• Analysis of mast cell involvement in the different stages of multiple sclerosis and EAE.
• Overview of mast cell immunomodulatory drugs and their effects on MS and EAE models.

Main Results:

• Mast cells contribute to both innate and specific immunity.
• Evidence suggests mast cell participation in the development and progression of multiple sclerosis and EAE.
• Ketotifen fumarate's effect on EAE evolution was specifically investigated.

Conclusions:

• Mast cells represent a promising therapeutic target for managing multiple sclerosis.
• Further research into mast cell immunomodulatory drugs could lead to novel MS treatments.
• Targeting mast cells may offer a new strategy for neurodegenerative disease therapy.